The Increased Endogenous Sulfur Dioxide Acts as a Compensatory Mechanism for the Downregulated Endogenous Hydrogen Sulfide Pathway in the Endothelial Cell Inflammation
Da Zhang,Xiuli Wang,Xiaoyu Tian,Lulu Zhang,Guosheng Yang,Yinghong Tao,Chen Liang,Kun Li,Xiaoqi Yu,Xinjing Tang,Chaoshu Tang,Jing Zhou,Wei Kong,Junbao Du,Yaqian Huang,Hongfang Jin
DOI: https://doi.org/10.3389/fimmu.2018.00882
IF: 7.3
2018-04-30
Frontiers in Immunology
Abstract:Endogenous hydrogen sulfide (H<sub>2</sub>S) and sulfur dioxide (SO<sub>2</sub>) are regarded as important regulators to control endothelial cell function and protect endothelial cell against various injuries. In our present study, we aimed to investigate the effect of endogenous H<sub>2</sub>S on the SO<sub>2</sub> generation in the endothelial cells and explore its significance in the endothelial inflammation <i>in vitro</i> and <i>in vivo</i>. The human umbilical vein endothelial cell (HUVEC) line (EA.hy926), primary HUVECs, primary rat pulmonary artery endothelial cells (RPAECs), and purified aspartate aminotransferase (AAT) protein from pig heart were used for <i>in vitro</i> experiments. A rat model of monocrotaline (MCT)-induced pulmonary vascular inflammation was used for <i>in vivo</i> experiments. We found that endogenous H<sub>2</sub>S deficiency caused by cystathionine-γ-lyase (CSE) knockdown increased endogenous SO<sub>2</sub> level in endothelial cells and enhanced the enzymatic activity of AAT, a major SO<sub>2</sub> synthesis enzyme, without affecting the expressions of AAT1 and AAT2. While H<sub>2</sub>S donor could reverse the CSE knockdown-induced increase in the endogenous SO<sub>2</sub> level and AAT activity. Moreover, H<sub>2</sub>S donor directly inhibited the activity of purified AAT protein, which was reversed by a thiol reductant DTT. Mechanistically, H<sub>2</sub>S donor sulfhydrated the purified AAT1/2 protein and rescued the decrease in the sulfhydration of AAT1/2 protein in the CSE knockdown endothelial cells. Furthermore, an AAT inhibitor l-aspartate-β-hydroxamate (HDX), which blocked the upregulation of endogenous SO<sub>2</sub>/AAT generation induced by CSE knockdown, aggravated CSE knockdown-activated nuclear factor-κB pathway in the endothelial cells and its downstream inflammatory factors including ICAM-1, TNF-α, and IL-6. In <i>in vivo</i> experiment, H<sub>2</sub>S donor restored the deficiency of endogenous H<sub>2</sub>S production induced by MCT, and reversed the upregulation of endogenous SO<sub>2</sub>/AAT pathway <i>via</i> sulfhydrating AAT1 and AAT2. In accordance with the results of the <i>in vitro</i> experiment, HDX exacerbated the pulmonary vascular inflammation induced by the broken endogenous H<sub>2</sub>S production in MCT-treated rat. In conclusion, for the first time, the present study showed that H<sub>2</sub>S inhibited endogenous SO<sub>2</sub> generation by inactivating AAT <i>via</i> the sulfhydration of AAT1/2; and the increased endogenous SO<sub>2</sub> generation might play a compensatory role when H<sub>2</sub>S/CSE pathway was downregulated, thereby exerting protective effects in endothelial inflammatory responses <i>in vitro</i> and <i>in vivo</i>.
immunology